PATENT CLAIM ANALYSIS

Application Number: 15751134
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["424", "085200"]

Abstract:
Methods of treating subjects having a cancer-related disease, disorder, or condition, or preventing the occurrence of such a disease, disorder or condition, via the administration of a PEG-IL-10 agent in combination with an IL-15 agent are provided.

Claim (Index 31):
The method of  claim 30 , wherein the solid tumor is selected from the group consisting of breast cancer, prostate cancer, lung cancer, liver cancer, pancreatic cancer, brain cancer, stomach cancer, ovarian cancer, kidney cancer, testicular cancer, and melanoma.

Metadata:
- Claim Count in Document: 126.0
- Percentile: 88.0
- Lexical Diversity: 1.53571
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15513825', '15543949', '14908992', '14779929', '15328882']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7322450494844873
- 35 USC 102 Novelty (BERT): 0.5340256812685691
- Combined Prediction Score: 0.7124231126628956
- Mean Citation Score: 325.5789660000001
- Max Citation Score: 340.58798
- Similarity Product: 203.18658608355165

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test